Search clinical trials for: sema4a

Total 2 results

Assistance Publique - Hôpitaux de Paris

Recruiting

Angiogenic Biomarkers in Juvenile Idiopathic Arthritis (MAJIC)

Juvenile Idiopathic Arthritis (JIA)

France
Providence Health & Services
Bristol-Myers Squibb; Milton S. Hershey Medical Center

Withdrawn

Sema 4A as a Marker for Inflammatory Disease in Multiple Sclerosis (Sema4A MS)

Multiple Sclerosis | Relapsing Multiple Sclerosis

United States

3

Subscribe